Christopher Stewart is recorded as Chief Accounting Officer at Aeluma, Inc. (ALMU) since August 4, 2025 and CFO at Aeluma, Inc. (ALMU). The newest filing on record that lists Christopher Stewart as CFO at Aeluma, Inc. (ALMU) is dated December 2, 2025. Earlier roles on record: CFO at Bionano Genomics, Inc. (BNGO) until September 11, 2023. Aeluma, Inc. reported in an 8-K filed August 8, 2025 that Christopher Stewart was appointed Principal Accounting Officer, effective August 4, 2025. Aeluma, Inc. reported in an 8-K filed August 8, 2025 that Christopher Stewart was appointed Chief Financial Officer (CFO)/Principal Accounting Officer, effective August 4, 2025. Bionano Genomics, Inc. reported in an 8-K filed August 14, 2023 that Christopher Stewart resigned as Chief Financial Officer, effective September 11, 2023. The proxy statement of Bionano Genomics, Inc. reports total compensation of $252,378 for Christopher Stewart in fiscal 2020, including a base salary of $18,027. Disclosed compensation is on record for 2 fiscal years. Christopher Stewart has spoken on 6 earnings calls across 2 companies, most recently for Aeluma, Inc. on November 12, 2026. Those appearances were for Aeluma, Inc. (ALMU) and Bionano Genomics, Inc. (BNGO). Aeluma, Inc. is classified in the Semiconductors industry within the Technology sector. Other companies whose calls Christopher Stewart spoke on are classified in the Healthcare sector. Other leadership on record at Aeluma, Inc. includes Jonathan Klamkin (CEO and Board Member), James Seo (CFO), Lee McCarthy (CFO and COO) and 6 others.
“As of August 4, 2025, Aeluma, Inc. (the "Company"), has appointed Christopher Stewart ("Stewart") as its full time Chief Financial Officer (CFO)/Principal Accounting Officer, taking over for Mr. James Seo ("Seo") who was serving as interim CFO/Principal Accounting Officer.”
Aeluma, Inc. Form 8-K, filed August 8, 2025
· Read the filing
“As of August 4, 2025, Aeluma, Inc. (the "Company"), has appointed Christopher Stewart ("Stewart") as its full time Chief Financial Officer (CFO)/Principal Accounting Officer, taking over for Mr. James Seo ("Seo") who was serving as interim CFO/Principal Accounting Officer.”
Aeluma, Inc. Form 8-K, filed August 8, 2025
· Read the filing
Christopher Stewart on recent calls
“Turning to our financial results for the first fiscal quarter of 2027, revenue was $568,000 compared to $1.4 million in the first fiscal quarter of 2026 and was generated primarily from government R&D contracts.”
“Over the last year, the opportunity for Aluma, particularly in the AI data center interconnect market, has really come into focus. Census projections for the size of the opportunity continue to increase dramatically.”
“For the fiscal third quarter, revenue was $1.2 million compared to $1.3 million in the third quarter of last year and $1.3 million in the second quarter of fiscal 2026.”
“Moving on to our fiscal second quarter 2026 financial results, revenue was $1.3 million compared to $1.6 million in the second quarter of last year, fiscal 2025, and $1.4 million in the first quarter of fiscal 2026.”
“The third quarter of 2022 was another outstanding quarter for Bionano. As Erik mentioned, we recorded significant year-over-year revenue growth and continued growth in the installed base of our Sapphire systems.”
